Loading stock data…
MLAB
$103.31+3.31 (+3.31%)
Market ClosedLast close May 1
Mesa Laboratories, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Mesa Laboratories, Inc. in the Technology sector is trading at $103.31. The stock is currently 21% below its 52-week high of $131.20, remaining 30.4% above its 200-day moving average. Technical signals show neutral RSI of 59 and bearish MACD signal, explaining why MLAB maintains its current momentum and trend strength. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 59) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
AAPLMSFTGOOGL
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$103.31
Potential Downside
88%
Whystock Fair Value$12.43
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus2 analysts
Mean target$104.50+1.2%
Range$94.00 – $115.00
Fundamentals
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control seg...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$535.35M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
149.08
Beta
Defensive asset. Lower volatility than the S&P 500.
0.89
Div Yield
Strong income play. Yield provides a meaningful total return floor.
66.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-0.33%
Volume
Today's trading volume
218,422
Recent News
Undervalued Small Caps With Insider Buying Across Regions To Consider
Over the last 7 days, the United States market has risen by 4.0%, contributing to a remarkable 39% increase over the past year, with earnings projected to grow by 16% annually in the coming years. In this dynamic environment, identifying good stocks often involves looking for companies that are not only undervalued but also show signs of insider confidence, such as recent buying activity.
Here’s Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB)
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across all major indices, yet underlying conditions revealed extreme volatility and market leadership. A copy of the letter can be downloaded here. In Q4 2025, Conestoga Capital Advisors Small Cap Strategy […]
Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
Most readers would already be aware that Mesa Laboratories' (NASDAQ:MLAB) stock increased significantly by 22% over the...
Mesa Labs: Fiscal Q3 Earnings Snapshot
LAKEWOOD, Colo. AP) — Mesa Laboratories Inc. MLAB) on Tuesday reported earnings of $3.6 million in its fiscal third quarter.
Mesa Laboratories' (NASDAQ:MLAB) Dividend Will Be $0.16
The board of Mesa Laboratories, Inc. ( NASDAQ:MLAB ) has announced that it will pay a dividend of $0.16 per share on...